Sarah Cannon — Nashville, Tennessee

Sarah Cannon is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon has participated in 21 clinical trials with 4 currently active.

Therapeutic areas: Ovarian Cancer, Advanced Colorectal Cancer, Advanced Solid Tumors With HER2 Abnormalities.

Sponsors: Ellipses Pharma, Daiichi Sankyo, Taiho Oncology, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon?

Sarah Cannon has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon conducted?

Sarah Cannon has 21 clinical trials on record, with 4 currently active. Their work covers Ovarian Cancer, Advanced Colorectal Cancer, Advanced Solid Tumors With HER2 Abnormalities.

Is Sarah Cannon accredited by Crixeo Clinical Trials?

Sarah Cannon has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.